Nimbex and Bumex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nimbex (cisatracurium besylate) and Bumex (bumetanide). Common drug interactions include pleural effusion among females and cytolytic hepatitis among males.
The phase IV clinical study analyzes what interactions people have when they take Nimbex and Bumex. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Nimbex?
Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,546 Nimbex users. Check the latest studies of Nimbex.
What is Bumex?
Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.
13 people who take Nimbex and Bumex together, and have interactions are studied.

What are the common drug interactions of Nimbex and Bumex, by gender? *:
female:
- Pleural effusion (water on the lungs)
- Pyrexia (fever)
- Septic shock (shock due to blood infection)
- Acute leukaemia (blood cancer)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Alopecia (absence of hair from areas of the body)
- Anal fissure
- Atelectasis (partial or complete collapse of the lung)
- Blood pressure decreased
male:
- Cytolytic hepatitis (dissolution or destruction of a liver cell)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Body temperature increased
- Capillary leak syndrome (capillary leaks plasma)
- Cardiac arrest
- Death
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Diarrhoea
- Enterocolonic fistula
- Fatigue (feeling of tiredness)
What are the common drug interactions of Nimbex and Bumex, by age (0-1 to 60+)? *:
0-1:
- Capillary leak syndrome (capillary leaks plasma)
- Hypotension (abnormally low blood pressure)
2-9:
- Pleural effusion (water on the lungs)
- Pyrexia (fever)
- Septic shock (shock due to blood infection)
- Acute leukaemia (blood cancer)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Alopecia (absence of hair from areas of the body)
- Anal fissure
- Atelectasis (partial or complete collapse of the lung)
- Blood pressure decreased
10-19:
- Body temperature increased
- Cardiac arrest
- Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
20-29:
- Death
30-39:
n/a
40-49:
n/a
50-59:
- Cytolytic hepatitis (dissolution or destruction of a liver cell)
- Blood creatinine increased
- Death
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Diarrhoea
- Enterocolonic fistula
- Fatigue (feeling of tiredness)
- Gamma-glutamyltransferase increased
- Histiocytosis haematophagic
- Infectious mononucleosis (infection usually caused by the epstein-barr virus)
60+:
- Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
What are the existing conditions these people have? *
- Respiratory Tract Infection: 3 people, 23.08%
- Fluid Overload (too much fluid in the blood): 2 people, 15.38%
- Adenovirus Infection: 2 people, 15.38%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 15.38%
- Wound: 1 person, 7.69%
- Hypoglobulinaemia (deficiency of globulin in the bloodstream): 1 person, 7.69%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 7.69%
- Hypersensitivity: 1 person, 7.69%
- Hyperkalemia (damage to or disease of the kidney): 1 person, 7.69%
- High Blood Pressure: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Nimbex and Bumex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Nimbex and Bumex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nimbex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Bumex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nimbex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bumex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cisatracurium besylate and bumetanide (the active ingredients of Nimbex and Bumex, respectively), and Nimbex and Bumex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Theophylline cause Multiple Allergies? - a second ago
- Avonex and Hair Thinning for Women aged 50-59 - 8 seconds ago
- Avonex and Loss Of Hair for Women aged 50-59 - 8 seconds ago
- Avonex and Hairloss for Women aged 50-59 - 9 seconds ago
- Avonex and Baldness for Women aged 50-59 - 9 seconds ago
- Avonex and Alopecia for Women aged 50-59 - 9 seconds ago
- Avonex and Hair Loss for Women aged 50-59 - 10 seconds ago
- Lorazepam and Respiratory Arrest for Women aged 20-29 - 13 seconds ago
- Lorazepam and Respiration Slowed Or Stopped for Women aged 20-29 - 13 seconds ago
- Lorazepam and Not Breathing for Women aged 20-29 - 14 seconds ago